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T follicular helper (Tfh) cells are crucial for generating humoral immune responses. In this issue of Immunity,
Schmitt et al. (2009) reveal the differentiation of human Tfh cells is dependent on dendritic cell-derived
interleukin-12.It has been over 20 years since Mosmann
and Coffman first published the T helper
(Th) 1-Th2 cell hypothesis. By studying
murine CD4+ T cell clones, they demon-
strated that CD4+ T cells could differen-
tiate into distinct subsets with unique
effector function (reviewed in Dong,
2008; Romagnani, 1994; Zhou et al.,
2009). Subsequent studies established
that this process was dependent on the
cytokines present at the time of activa-
tion. Thus, interleukin-12 (IL-12) was
required for the generation of interferon
(IFN)-g- and tumor necrosis factor-a-
producing Th1 cells, which function in
cellular immune responses to viruses and
bacteria. Alternatively, IL-4-primed naive
CD4+ T cells became Th2 cells producing
IL-4 and IL-13 that are important for
protection against extracellular parasites
and allergic responses and may also
have a role in humoral immunity (Dong,
2008; Romagnani, 1994; Zhou et al.,
2009). IL-12 and IL-4 achieve these effects
through the action of the transcription
factor pairs signal transducer and acti-
vator of transcription 4 (STAT4)-T box
transcription factor (T-bet) and STAT6-
GATA binding protein 3 (GATA3), respec-
tively (Dong, 2008; Zhou et al., 2009).
Although Th1 and Th2 cell populations
were verified in humans, a degree of plas-
ticity was also revealed as CD4+ T cells
producing both IFN-g and IL-4 were de-
tected (Romagnani, 1994). Nevertheless,
this simplified view of naive CD4+ T cell
differentiation whereby a predominant
cytokine induced defined transcription
factors resulting in the generation of
a distinct effector subset has been used
for the identification of other Th cell popu-
lations with specialized functions. This
includes regulatory T (Treg) cells, which
are important in immune regulation and
are induced by transforming growth factor12 Immunity 31, July 17, 2009 ª2009 Elsevi(TGF)-b acting through the transcription
factor Forkhead box P3 (FoxP3), and
more recently Th17 cells, which are impor-
tant in controlling infection with extracel-
lular pathogens but are also pathogenic
in certain autoimmune conditions (Annun-
ziato et al., 2008; Dong, 2008; Zhou et al.,
2009). Although there is some controversy
surrounding the requirements for the
generation of human Th17 cells, it is likely
to involve IL-23 and IL-6 (and possibly
TGF-b) acting through STAT3 and retinoic
acid-related orphan receptor (ROR) gt
(Annunziato et al., 2008; Dong, 2008).
Another subset of Th cells is T follicular
helper (Tfh) cells. Tfh cells express the
chemokine receptor CXCR5 and high
amounts of the costimulatory molecules
CD40 ligand (CD40L) and inducible costi-
mulator (ICOS) and the cytokine IL-21.
This suite of effector molecules allows
Tfh cells to localize to B cell follicles
and germinal centers (GCs) where
they are positioned to guide the differenti-
ation of B cells into memory and plasma
cells (King et al., 2008). Although Tfh
cells were first described in 2000, the
mechanisms underlying their develop-
ment remain incompletely defined. For
instance, although it was recently re-
ported that IL-6, IL-21, and STAT3 are
required for the generation of murine Tfh
cells (King et al., 2008; Nurieva et al.,
2008; Suto et al., 2008), it is unknown
whether the same factors are involved in
the development of human Tfh cells.
In this issue of Immunity, Schmitt et al.
(2009) show that Toll-like receptor (TLR)-
or CD40L-stimulated DCs induce the
in vitro differentiation of human naive
CD4+ T cells into Tfh-like cells, defined
by IL-21 production (Schmitt et al., 2009).
Functional analysis of DC-derived cyto-
kines demonstrated that IL-12 and the
related cytokine IL-23 were responsibleer Inc.for this process. Similar to studies in
mice (Nurieva et al., 2008; Suto et al.,
2008), IL-21 could also induce its own
production (Figure 1). Interestingly, the
effects of IL-21 and IL-23 were dramati-
cally less than that of IL-12 (Schmitt
et al., 2009). These in vitro-generated
IL-21-expressing human CD4+ T cells
functionally resembled Tfh cells in vivo in-
asmuch that they induced Ig secretion by
cocultured B cells in an IL-21- and ICOS-
dependent manner (Figure 1). In light of
the prominent role of IL-12 in generating
Th1 cells, the finding that it also induced
Tfh-like cells may seem unexpected.
These results however are actually consis-
tent with DCs being a prominent producer
of IL-12 and their pivotal role in priming
naive CD4+ T cells for differentiation into
specific effector cell fates. In contrast to
IL-12 and IL-23, IL-21 is not produced by
DCs. Thus, IL-21 secreted by IL-21-stimu-
lated CD4+ T cells may act in a paracrine
manner to promote IL-21 synthesis by
additional naive CD4+ T cells or in an auto-
crine manner to sustain endogenous IL-21
production (Figure 1).
The population of IL-21+CD4+ T cells
induced by IL-12 contained IFN-g+ and
IFN-g subsets. The functional similarities
and differences between the IL-21+IFN-g+
and IL-21+IFN-g CD4+ T cells, and
whether one subset can give rise to the
other, remain to be determined. It is
possible that IL-21+IFN-g+ Th1-Tfh-like
cells could convert into IL-21+IFN-g
Tfh-like cells in response to appropriate
signals provided by the microenvironment
within B cell follicles. This would resemble
murine Treg and Th2 cells that have re-
cently been reported to differentiate into
Tfh cells in vivo during responses to
specific pathogens or in compartmental-
ized lymphoid tissues (reviewed in Zhou
et al., 2009). Interestingly, IL-21+IFN-g+
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21+IFN-g T cells did not (Schmitt et al.,
2009), suggesting that IL-12 acts via
a T-bet-dependent pathway to generate
IL-21+IFN-g+ cells, whereas IL-21+IFN-g
CD4+ T cells arise independently of
T-bet. B cell lymphoma-6 (Bcl-6) is highly
expressed by both human and murine Tfh
cells and has been proposed to be
a ‘‘master regulator’’ of Tfh cell differenti-
ation (King et al., 2008). Thus, although
expression of Bcl-6 by IL-12-stimulated
CD4+ T cells was not assessed (Schmitt
et al., 2009), it is tempting to speculate
that the IL-12-mediated differentiation of
naive CD4 T cells into IL-21+IFN-g cells
involves this transcription factor (Figure 1).
This would be consistent with the
induction of Bcl6 expression in murine
CD4+ T cells cultured under ‘‘Tfh’’ cell-
polarizing conditions (Nurieva et al.,
2008). However, the specific role of Bcl-
6 in regulating commitment to a Tfh cell
fate awaits formal examination.
Cytokines mediate their effects by acti-
vating specific STAT signaling pathways.
By reducing expression of STAT3 and
STAT4 in primary human CD4+ T cells by
siRNA transfection, it was found that IL-
12 induced IL-21 via a STAT4-dependent
pathway, whereas the effects of IL-21 and
IL-23 required STAT3 (Schmitt et al.,
2009) (Figure 1). The fact that IL-12 and
IL-23 generate IL-21-expressing CD4+
T cells via distinct mechanisms raises
the possibility that the effector cells
arising from these cultures may have
functional or molecular differences. IL-23
has an important role in generating Th17
cells from naive human CD4+ T cells
(Annunziato et al., 2008). Although Schmitt
et al. (2009) reported that IL-23-induced
IL-21+CD4+ T cells did not express IL-
17A, human CD4+ T cells activated by
IL-23 express RORgt, yet lack IL-17
(Annunziato et al., 2008). Because IL-23
can induce RORgt and IL-21 in a STAT3-
dependent manner in murine Th17 cells
(Dong, 2008), it is possible that the IL-
21+ cells arising from human naive CD4+
T cells cultured with IL-23 are related to
Th17 cells. This is not incompatible with
their ability to provide B cell help in vitro
because human Th17 cells are as efficient
as Th1 and Th2 cells at inducing T cell-
dependent B cell differentiation (Annun-
Figure 1. Differentiation of Human Tfh Cells Is Dependent on DC-Derived IL-12 and IL-23
CD40 and TLR-stimulated DCs secrete a large spectrum of cytokines. Of these, Schmitt et al. (2009)
showed that IL-12 and IL-23 induced the differentiation of naive CD4+ T cells into IL-21-producing effector
cells. IL-12 generated IFN-g+IL-21+ and IFN-gIL-21+ cells via STAT4. The differentiation of IFN-g+IL-21+
T cells involves T-bet, whereas that of IFN-gIL-21+ cells probably depends on Bcl-6. In contrast, IL-23
acts via STAT3 and perhaps Bcl-6 and/or RORgt to induce IFN-gIL-21+ cells, which may also exhibit
features of Th17 cells. IL-21 produced by Tfh cells may act in an autocrine manner to further promote
Tfh cells. The signals required to maintain CXCR5 expression that allow precursor Tfh cells to migrate
to follicles and interact with B cells are unknown. The two-way interaction that ensues results in the gener-
ation of bona fide Tfh cells that mediate the differentiation of B cells into plasma cells through the
combined actions of IL-21, ICOS and presumably CD40L.Immuziato et al., 2008). On the basis of this
scenario, it will be interesting to determine
whether RORgt has a role in inducing
IL-21 by these STAT3 activating cytokines
(Figure 1).
Another important finding from this
study (Schmitt et al., 2009) is that su-
bstantial differences appear to exist for
the generation of human versus murine
Tfh cells, inasmuch that IL-12 failed to
induce IL-21 production from murine
CD4+ T cells in vitro (Suto et al., 2008).
Similarly, although IL-6 induces IL-21 in
murine CD4+ T cells (Nurieva et al., 2008;
Suto et al., 2008), this was not the case
for humans (Schmitt et al., 2009). This rai-
ses the logistical issue of determining the
physiological significance of the IL-12-
STAT4 pathway in regulating Tfh cell
formation and subsequent humoral im-
mune responses in humans in vivo.
Although this may appear challenging it
is certainly achievable because individ-
uals have been identified with specific
immunodeficiencies due to mutations in
IL-12B, IL-12RB1, and TYK2 (which is
downstream of IL-12-IL-23 signaling)
(Marodi and Notarangelo, 2007). Further-
more, CD4+ T cells in patients recovering
from stem cell transplants are STAT4 defi-
cient; however, the mechanism underlying
this has not been determined (Robertson
et al., 2005). Thus, such ‘‘experiments of
nature’’ will provide a valuable opportunity
to determine the role of the IL-12-STAT4
pathway in generating human Tfh cells
in vivo and will establish the feasibility of
targeting this pathway to modulate Tfh
cells in cases of autoimmunity, immuno-
deficiency, and vaccination.
One outstanding question is to under-
stand exactly what a Tfh cell is and how
it fits into the scheme of CD4+ T cell
differentiation. Tfh cells may belong to a
specific lineage of effector CD4+ T cells,
similar to Th1, Th2, Th17, and Treg cells.
However, numerous types of human
CD4+ T cells can produce IL-21 and
provide help to B cells: tissue-resident
CXCR5+ Tfh cells, IL-12-induced IFN-
g+IL-21+ Th1-Tfh-like and IFN-gIL-21+
Tfh-like cells, NKT cells, Th17 cells, and
gd T cells. Furthermore, CXCR5 can be
expressed on subsets of these cells and
is induced on all T cells after activation
in vivo and in vitro (King et al., 2008).
Thus, an alternative possibility is that
Tfh cells correspond to a discrete differ-
entiation stage of other effector cellnity 31, July 17, 2009 ª2009 Elsevier Inc. 13
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ticity of CD4+ T cell differentiation (Zhou
et al., 2009). This is supported by the
ability of murine Treg and Th2 cells to
develop into Tfh cells in vivo. A precise
definition of a bona fide Tfh cell is predi-
cated on their positioning within GCs
where they can then deliver ‘‘help,’’ a
process that involves the coordinated
expression and function of chemokine
receptors, but still remains incompletely
defined (King et al., 2008). Although the
identification by Schmitt et al. of IL-12
(and IL-23) as key inducers of IL-21
production by naive human CD4+ T cells
represents an important advance in our
understanding of the requirements for
generating human Tfh-like cells, these14 Immunity 31, July 17, 2009 ª2009 Elseviecytokines did not influence expression of
CXCR5. Thus, to improve our knowledge
of the complexities of Tfh cells, future
studies will need to focus on elucidating
the mechanisms that underlie the migra-
tion and positioning of IL-21-producing
effector cells within B cell follicles and
GCs such that they can function as
genuine Tfh cells.
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